A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates

Vaccines against SARS-CoV-2 have been distributed at massive scale in developed countries, and have been effective at preventing COVID-19. Access to vaccines is limited, however, in low- and middle-income countries (LMICs) due to insufficient supply, high costs, and cold storage requirements. New va...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalvie, Neil C., Tostanoski, Lisa H., Rodriguez-Aponte, Sergio A, Kaur, Kawaljit, Bajoria, Sakshi, Kumru, Ozan S., Martinot, Amanda J., Chandrashekar, Abishek, McMahan, Katherine, Mercado, Noe B., Yu, Jingyou, Chang, Aiquan, Giffin, Victoria M., Nampanya, Felix, Patel, Shivani, Bowman, Lesley, Naranjo, Christopher A., Yun, Dongsoo, Flinchbaugh, Zach, Pessaint, Laurent, Brown, Renita, Velasco, Jason, Teow, Elyse, Cook, Anthony, Andersen, Hanne, Lewis, Mark G., Camp, Danielle L., Silverman, Judith Maxwell, Kleanthous, Harry, Joshi, Sangeeta B., Volkin, David B., Biswas, Sumi, Love, J. Christopher, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288147/
https://www.ncbi.nlm.nih.gov/pubmed/34282417
http://dx.doi.org/10.1101/2021.07.13.452251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288147/
https://www.ncbi.nlm.nih.gov/pubmed/34282417
http://dx.doi.org/10.1101/2021.07.13.452251

Ejemplares similares